What prescription‑strength proton‑pump inhibitor (PPI) is recommended for an adult with frequent or severe heartburn refractory to over‑the‑counter antacids and H2‑blockers?

Prescription-Strength PPI for Refractory Heartburn

For an adult with frequent or severe heartburn that has failed over-the-counter antacids and H2-blockers, start a prescription-strength proton pump inhibitor (PPI) at standard once-daily dosing (e.g., omeprazole 20 mg, lansoprazole 30 mg, or esomeprazole 20-40 mg) taken 30 minutes before breakfast for 4-8 weeks. 1

Why PPIs Are the Strongest Option

PPIs provide sustained inhibition of gastric acid production and are superior to both antacids and H2-receptor antagonists for controlling gastric acid and treating frequent heartburn 2. The 2022 AGA guidelines explicitly recommend a 4-8 week trial of single-dose PPI therapy for patients with typical reflux symptoms (heartburn, regurgitation, non-cardiac chest pain) without alarm features 1.

Evidence Supporting PPI Superiority

• PPI-start strategies achieve heartburn relief in 55% of patients at 4 weeks compared to only 27% with H2RA-start strategies (P < 0.001), though both approaches eventually achieve similar relief rates (88% vs 87%) by 16 weeks 3
• The faster symptom control with PPIs translates to better quality of life during the initial treatment period
• H2-blockers rapidly develop tolerance with repeat dosing, limiting their effectiveness for chronic management 2

Dosing Algorithm

Initial Treatment (Weeks 1-8)

• Start with standard once-daily PPI dosing 30 minutes before breakfast 1
  • Omeprazole 20 mg
  • Lansoprazole 30 mg
  • Esomeprazole 20-40 mg

If Inadequate Response at 4-8 Weeks

First, assess medication compliance before escalating therapy 1

Then choose one of two options:

1. Increase to twice-daily dosing (not FDA-approved but commonly used) 1
2. Switch to a more effective acid suppressive agent at once-daily dosing 1

If Still Inadequate Response

• Perform upper endoscopy to look for:

  • Erosive esophagitis (Los Angeles classification)
  • Barrett's esophagus (≥3 cm is significant)
  • Hiatal hernia characteristics 1

• If endoscopy shows no erosive disease (Los Angeles B or greater) or long-segment Barrett's, perform prolonged wireless pH monitoring off PPI (96-hour preferred) to confirm true GERD vs. functional heartburn 1

Important Caveats

When to Refer Immediately

Perform endoscopy before empiric PPI trial if:

• Alarm symptoms are present (dysphagia, weight loss, bleeding, anemia)
• Isolated extra-esophageal symptoms (chronic cough, hoarseness) without typical heartburn 1

Long-Term Management

• If PPI therapy continues beyond 12 months without objective GERD diagnosis, re-evaluate appropriateness and consider prolonged wireless reflux monitoring off PPI to justify long-term therapy 1
• Once symptoms resolve, taper to the lowest effective dose or convert to on-demand therapy if possible 1

Adjunctive Therapies for Breakthrough Symptoms

Personalize based on symptom pattern 1:

• Alginate antacids for breakthrough symptoms
• Nighttime H2-receptor antagonists for nocturnal symptoms (note: concomitant H2RA + PPI can enhance acid suppression 4)
• Baclofen for regurgitation or belch-predominant symptoms
• Prokinetics for coexistent gastroparesis

Common Pitfall

Do not assume all "heartburn" is GERD. Patients with functional heartburn or reflux hypersensitivity may need neuromodulation therapy and/or behavioral interventions (hypnotherapy, cognitive behavioral therapy, diaphragmatic breathing) rather than escalating acid suppression 1.